Jump to Content

News:

Recombinant Pure PDGF Improves Aesthetic Results and Patient Satisfaction Following RF Microneedling: A Prospective, Randomized, Controlled Clinical Trial.

Lynch SE, Huxel ST, Bond R, Biron J, Gold M.

Journal of Cosmetic Dermatology. 2025 Sep;24(9):e70425. DOI:10.1111/jocd.70425

Disclaimer: ariessence® pure PDGF+ is marketed solely as a topical cosmetic product and is not intended for any other use. Use of ariessence for any other purposes – including administration via injection, for the diagnosis, cure, mitigation, treatment, or prevention of any disease or condition, or to affect the structure or function of the body – is not approved by the FDA.

View article here

Journal of Cosmetic Dermatology: Recombinant Pure PDGF Improves Aesthetic Results and Patient Satisfaction Following RF Microneedling: A Prospective, Randomized, Controlled Clinical Trial

Trending Posts Stay on top of our latest insights

Are you a Healthcare Professional?

ariessence pure PDGF+
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.